{"nctId":"NCT02250651","briefTitle":"Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension","startDateStruct":{"date":"2014-12-15","type":"ACTUAL"},"conditions":["Glaucoma, Open-Angle","Ocular Hypertension"],"count":528,"armGroups":[{"label":"Bimatoprost SR 15 μg","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost SR","Other: Sham: Applicator Without Needle","Drug: Active Comparator: Timolol 0.5%","Drug: Timolol Vehicle (placebo)"]},{"label":"Bimatoprost SR 10 μg","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost SR","Other: Sham: Applicator Without Needle","Drug: Active Comparator: Timolol 0.5%","Drug: Timolol Vehicle (placebo)"]},{"label":"Timolol 0.5%: Comparator","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Sham: Applicator Without Needle","Drug: Active Comparator: Timolol 0.5%"]}],"interventions":[{"name":"Bimatoprost SR","otherNames":[]},{"name":"Sham: Applicator Without Needle","otherNames":[]},{"name":"Active Comparator: Timolol 0.5%","otherNames":[]},{"name":"Timolol Vehicle (placebo)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n\\- Diagnosis of either open-angle glaucoma or ocular hypertension in each eye and both eyes require IOP-lowering treatment.\n\nExclusion Criteria:\n\n* Previous enrollment in another Allergan Bimatoprost SR Study\n* Eye surgery (including cataract surgery) and/or any eye laser surgery within the past 6 months in the study eye\n* Anticipated need for laser eye surgery within the first 52 weeks of the study duration\n* History of glaucoma surgery","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Intraocular Pressure (IOP) in the Study Eye to Week 12 (Hours 0 and 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. A mixed-effects model with repeated measures (MMRM) was used for analyses. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.47","spread":"0.30"},{"groupId":"OG001","value":"-6.18","spread":"0.30"},{"groupId":"OG002","value":"-6.11","spread":"0.30"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.16","spread":"0.28"},{"groupId":"OG001","value":"-6.72","spread":"0.28"},{"groupId":"OG002","value":"-6.36","spread":"0.29"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 2 (Hour 0)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.74","spread":"0.27"},{"groupId":"OG001","value":"16.92","spread":"0.27"},{"groupId":"OG002","value":"17.50","spread":"0.27"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 2 (Hour 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.09","spread":"0.25"},{"groupId":"OG001","value":"16.48","spread":"0.25"},{"groupId":"OG002","value":"17.19","spread":"0.25"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 6 (Hour 0)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.05","spread":"0.28"},{"groupId":"OG001","value":"16.93","spread":"0.28"},{"groupId":"OG002","value":"17.51","spread":"0.29"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 6 (Hour 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.13","spread":"0.26"},{"groupId":"OG001","value":"16.53","spread":"0.26"},{"groupId":"OG002","value":"17.18","spread":"0.27"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 12 (Hour 0)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.39","spread":"0.30"},{"groupId":"OG001","value":"17.68","spread":"0.30"},{"groupId":"OG002","value":"17.75","spread":"0.30"}]}]}]},{"type":"PRIMARY","title":"IOP in the Study Eye at Week 12 (Hour 2)","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.70","spread":"0.28"},{"groupId":"OG001","value":"17.15","spread":"0.28"},{"groupId":"OG002","value":"17.50","spread":"0.29"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in IOP in the Study Eye","description":"IOP is a measurement of the fluid pressure inside the study eye. Measurements were taken at Hours 0 and 2. The study eye is defined as the eye that meets the entry criteria. If both eyes meet the entry criteria, the eye with the higher IOP at Baseline Hour 0 will be selected as the study eye. If both eyes had the same IOP at Hour 0, then the right eye was designated as the study eye. MMRM was used for analyses. A negative change from baseline indicates an improvement and a positive change from baseline indicates a worsening.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.12","spread":"0.27"},{"groupId":"OG001","value":"-6.94","spread":"0.27"},{"groupId":"OG002","value":"-6.36","spread":"0.27"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.77","spread":"0.25"},{"groupId":"OG001","value":"-7.38","spread":"0.25"},{"groupId":"OG002","value":"-6.67","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.81","spread":"0.28"},{"groupId":"OG001","value":"-6.93","spread":"0.28"},{"groupId":"OG002","value":"-6.35","spread":"0.29"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.74","spread":"0.26"},{"groupId":"OG001","value":"-7.33","spread":"0.26"},{"groupId":"OG002","value":"-6.69","spread":"0.27"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":36,"n":176},"commonTop":["Conjunctival hyperaemia","Corneal endothelial cell loss","Conjunctival haemorrhage","Eye pain","Foreign body sensation in eyes"]}}}